GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Novartis India Ltd

Evonile Pharma gets CARE A; Stable rating for bank facilities

RATING ▲ Positive Development LOW RISK
📅 Filed on BSE: 07 Oct 2026, 06:02 PM IST  ·  BSE ID: ae8dd21e-a44b-48c4-8c79-c2d7c14fc721
View Original BSE Filing (PDF)
💡
In Simple Terms
The company, Evonile Pharma, received updated credit ratings for its loans and borrowings from an agency called CARE Ratings.
🤖 AI Summary
  • Evonile Pharma's bank facilities rated by CARE Ratings Limited on October 07, 2026.
  • Long Term Bank Facilities assigned a CARE A; Stable rating.
  • Long Term / Short Term Bank Facilities rated CARE A; Stable / CARE A2+.
  • The rating rationale will be available on the CARE Ratings website.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Long Term Bank Facilities Rating
CARE A; Stable
Long Term / Short Term Bank Facilities Rating
CARE A; Stable / CARE A2+
🏢 How This Affects the Company
💰
Financial Impact
These credit ratings provide an independent assessment of Evonile Pharma's ability to meet its financial obligations related to its bank facilities.
⚠️
Risk Impact
The assigned ratings, particularly the 'Stable' outlook, suggest a moderate level of risk associated with the company's credit profile as assessed by CARE Ratings.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this credit rating update.
👤
Who Is Affected
All shareholders are indirectly affected as credit ratings can influence the company's financial flexibility and borrowing capacity.
🔍
Management Signal
The company is actively engaging with credit rating agencies to provide transparency on its financial health to stakeholders.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Review of CARE Ratings' published rating rationale for detailed assessment.
Company's subsequent financial results disclosures.
Updates on any future credit rating reviews or changes.
LOW RISK Credit rating updates are routine disclosures and do not inherently introduce new risks.
💡 Investor Takeaway
Evonile Pharma's long-term bank facilities are rated CARE A; Stable, and its long-term/short-term facilities are rated CARE A; Stable / CARE A2+ by CARE Ratings, indicating a stable credit assessment.
⚖️ Strengths & Concerns

✅ Positives

  • Long Term Bank Facilities assigned a CARE A; Stable rating by CARE Ratings Limited.
  • Long Term / Short Term Bank Facilities rated CARE A; Stable / CARE A2+ by CARE Ratings Limited.
❓ Frequently Asked Questions
What credit ratings has Evonile Pharma received for its bank facilities?
Evonile Pharma's Long Term Bank Facilities received a CARE A; Stable rating, and its Long Term / Short Term Bank Facilities received CARE A; Stable / CARE A2+.
Which agency assigned the credit ratings to Evonile Pharma?
The credit ratings were assigned by CARE Ratings Limited on October 07, 2026.
Where can I find the rating rationale for Evonile Pharma's credit ratings?
The rating rationale issued by CARE Ratings Limited will be available on their website and has also been made available on the company's website.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.